China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Price:
18.58
CNY
-2.88%
Market Closed
Market Cap:
¥9.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
CN |
|
Staffing 360 Solutions Inc
NASDAQ:STAF
|
US |
|
Vertoz Advertising Ltd
NSE:VERTOZ
|
IN |
|
A
|
Alternus Energy Group PLC
OTC:ALTNF
|
IE |
|
FNM SpA
MIL:FNM
|
IT |
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
H
|
HCA Healthcare Inc
SWB:2BH
|
US |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
US |
Multiples-Based Value
The
Multiples-Based Value for
China Resources Boya Bio pharmaceutical Group Co Ltd (300294)
under the Base Case is
hidden
CNY.
Compared with the current market price of 18.58 CNY, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China Resources Boya Bio pharmaceutical Group Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
9.4B CNY | 4.6 | 83.1 | 20 | 20 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.6B USD | 6 | 87.8 | 14.6 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD | 9.2 | 28 | 21 | 22 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR | 11.9 | 38.2 | 41.3 | 42.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 3 | 32.9 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
